Chitosan Nanoparticle-Delivered Scorpion Potassium Channel Peptide Treats Pain and Inflammation | Research

The takeaway

Scorpion-derived potassium channel-modulating peptide delivered via chitosan nanoparticles ameliorated D-galactose-induced tissue damage through anti-inflammatory and antioxidant mechanisms.

Venom in a nanoparticle
Chitosan nanoparticles turn a fragile scorpion venom peptide into a deliverable medicine that reduces inflammation and oxidative damage

What the researchers found

Scorpion Kv peptide in chitosan NPs: ameliorated D-galactose-induced tissue damage through anti-inflammatory and antioxidant mechanisms with improved delivery.

Why it matters

Venom peptides need delivery solutions. Chitosan nanoparticles provide biocompatible, scalable protection and delivery.

How the study worked

Chitosan nanoparticle encapsulation of scorpion Kv peptide, D-galactose aging/inflammation model, anti-inflammatory and antioxidant assessment.

What this study cannot tell us

D-galactose model is general aging/inflammation, not specific to a disease. In vivo pharmacokinetics not fully characterized.

How to read the evidence

Preclinical proof-of-concept with nanoparticle delivery validation.

When this study was published

Published in 2025.

The bigger picture

Practical delivery of venom-derived peptides through biodegradable nanoparticles brings these molecules closer to therapeutic application.

Questions still open

Which potassium channel subtype is the peptide targeting?
Would this approach work for pain-specific venom peptides?
How does chitosan NP delivery compare to PEGylation for venom peptides?

Common questions

How do you make a scorpion venom peptide into medicine?

By loading it into chitosan (a natural polymer) nanoparticles that protect the peptide and deliver it to where it's needed. This study showed it reduced inflammation and oxidative damage.

Is chitosan safe?

Chitosan is a natural polymer from crustacean shells, biodegradable, and biocompatible. It is widely used in pharmaceutical and food applications.

Read the original research

Ameliorative effects of chitosan nanoparticles containing a scorpion-derived potassium channel inhibitory peptide (alpha-KTx 3.13) in a juvenile model of rheumatoid arthritis.

International immunopharmacology, 168(Pt 2), 115817

View on PubMed ↗Publisher’s paper ↗

Citation

Kazemi-Lomedasht, Fatemeh; Eftekhari, Zohre; Chiani, Mohsen; Ramezanpour, Sorour; Montazeri, Ayda. (2026). Ameliorative effects of chitosan nanoparticles containing a scorpion-derived potassium channel inhibitory peptide (alpha-KTx 3.13) in a juvenile model of rheumatoid arthritis.. International immunopharmacology, 168(Pt 2), 115817. https://doi.org/10.1016/j.intimp.2025.115817